granupas (previously para-aminosalicylic acid lucane)
eurocept international b. v. - para-aminosalicylic acid - tuberculosis - antimycobacterials - granupas is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see section 4.4).consideration should be given to official guidance on the appropriate use of antibacterial agents.
pheburane
eurocept international b. v. - sodium phenylbutyrate - carbamoyl-phosphate synthase i deficiency disease - various alimentary tract and metabolism products - treatment of chronic management of urea-cycle disorders.
ucedane
eurocept international bv - carglumic acid - hyperammonemia; amino acid metabolism, inborn errors - other alimentary tract and metabolism products, - ucedane is indicated in treatment of:hyperammonaemia due to n-acetylglutamate synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.
rapydan 70 mg/70 mg medicated plaster
eurocept international bv - lidocaine; tetracaine - medicated plaster - 70 mg/70 milligram(s) - amides; lidocaine, combinations
amsidine 75 mg/1.5 ml concentrate and solvent for concentrate for solution for infusion
eurocept international bv - amsacrine - concentrate and solvent for concentrate for solution for infusion - 75 mg/1.5 millilitre(s) - other antineoplastic agents; amsacrine
amsidine 75mg/1.5ml concentrate and solvent for concentrate for solution for infusion
eurocept international bv trapgans 5, 1244rl ankeveen, netherlands - amsacrine - concentrate and solvent for solution for infusion - amsacrine 50 mg/ml - antineoplastic agents
amsalyo 75 mg powder for concentration for solution infusion
eurocept international bv - amsacrine - powder for solution for infusion - amsacrine
granupas
truemed ltd, israel - 4 - aminosalicylic acid - gastro resistant granules - 4 - aminosalicylic acid 4 g/sachet - 4-aminosalicylic acid - granupas is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
pheburane
truemed ltd, israel - sodium phenylbutyrate - granules - sodium phenylbutyrate 483 mg/g - sodium phenylbutyrate - pheburane is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase. it is indicated in all patients with neonatal-onset presentation (complete enzyme deficiencies, presenting within the first 28 days of life). it is also indicated in patients with late-onset disease (partial enzyme deficiencies, presenting after the first month of life) who have a history of hyperammonaemic encephalopathy.
amsidine 75mg/1.5ml solution for infusion ampoules and diluent
eurocept international bv - amsacrine - solution for infusion - 50mg/1ml